Skip to content
Screener

EyePoint, Inc. EYPT Asset turnover

Asset turnover at other companies

Merck & Co. logo
Merck & Co.MRK
0.5×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
0.1×0.0×
Regenxbio logo
RegenxbioRGNX
0.4×+0.1×
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
0.2×
HRO
HarrowHROW
0.7×0.0×

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.2B+69.1%
Enterprise value$1.11B+67.9%
P/S429.4×+416×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Calculated from EyePoint, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037

FAQ

What is EyePoint, Inc.'s asset turnover?
EyePoint, Inc. (EYPT) reported asset turnover of 0× in Q2 2026.
How has EyePoint, Inc.'s asset turnover changed year-over-year?
EyePoint, Inc.'s asset turnover decreased by 93.7% year-over-year, from 0.2× to 0×.
What is the long-term trend for EyePoint, Inc.'s asset turnover?
Over 5 years (2020 to 2025), EyePoint, Inc.'s asset turnover has grown at a -28.1% compound annual growth rate (CAGR), from 0.4× to 0.1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about EyePoint, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude